Transgenic rice seeds expressing altered peptide ligands against the M3 muscarinic acetylcholine receptor suppress experimental sialadenitis-like Sjögren’s syndrome

References

• Adamson T, Fox RI, Frisman DM, Howell FV. Immunohistologic analysis of lymphoid infiltrates in primary Sjögren’s syndrome using monoclonal antibodies. J Immunol. 1983;130:203–8.
   PubMed Web of Science ®Google Scholar
• Sumida T, Kato T, Hasunuma T, Maeda T, Nishioka K, Matsumoto I. Regulatory T cell epitope recognized by T cells from labial salivary glands of patients with Sjögren’s syndrome. Arthritis Rheum. 1997;40(12):2271–3.
   PubMedGoogle Scholar
• Gordon BP, Guy HC. Regulation of salivary gland function by autonomic nerves. Auton Neurosci. 2007; 133:3–18.
   PubMed Web of Science ®Google Scholar
• Bacman S, Berra A, Sterin-Borda L, Borda E. Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren’s syndrome. Invest Ophthalmol Vis Sci. 2001;42(2):321–7.
   PubMed Web of Science ®Google Scholar
• Naito Y, Matsumoto I, Wakamatsu E, Goto D, Sugiyama T, Matsumura R. Muscarinic acetylcholine receptor autoantibodies in patients with Sjögren’s syndrome. Ann Rheum Dis. 2004;64(3):510–1.
   Web of Science ®Google Scholar
• Nakamura Y, Wakamatsu E, Matsumoto I, Tomiita M, Kohno Y, Mori M, et al. High prevalence of autoantibodies to muscarinic-3 acetylcholine receptor in patients with juvenileonset Sjögren syndrome. Ann Rheum Dis. 2008;67(1):136–7.
   PubMed Web of Science ®Google Scholar
• Tsuboi H, Matsumoto I, Wakamatsu E, Nakamura Y, Iizuka M, Hayashi T, et al. New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren’s syndrome. Clin Exp Immunol. 2010;162(1):53–61.
   PubMed Web of Science ®Google Scholar
• Naito Y, Matsumoto I, Wakamatsu E, Goto D, Ito S, Tsutsumi A, et al. Altered peptide ligands regulate muscarinic acetylcholine receptor reactive T cells of patients with Sjögren’s syndrome. Ann Rheum Dis. 2006;65(2):269–71.
   PubMed Web of Science ®Google Scholar
• Dawson LJ, Stanbury J, Venn N, Hasdimir B, Rogers SN, Smith PM. Antimuscarinic antibodies in primary Sjögren’s syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Arthritis Rheum. 2006;54(4):1165–73.
   PubMed Web of Science ®Google Scholar
• Matusi M, Motomura D, Karasawa H, Fujikawa T, Jiang J, Komiya Y. Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc Natl Acad Sci USA. 2000;97:9579–84.
   PubMed Web of Science ®Google Scholar
• Iizuka M, Wakamatsu E, Tsuboi H, Nakamura Y, Hayashi T, Matsui M, et al. Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjögren’s syndrome-like sialadenitis. J Autoimmun. 2010;35(4):383–9.
   PubMed Web of Science ®Google Scholar
• Iizuka M, Tsuboi H, Matsuo N, Kondo Y, Asashima H, Matsui M, et al. The crucial roles of IFN-g in the development of M3 muscarinic acetylcholine receptor induced Sjögren’s syndrome like sialadenitis. Mod Rheumatol. 2013;23(3):614–6.
   PubMed Web of Science ®Google Scholar
• Iizuka M, Tsuboi H, Asashima H, Hirota T, Kondo Y, Matsui M, et al. M3 muscarinic acetylcholine receptor reactive IL-17 producing T cells promotes development of Sjögren’s syndrome like sialadenitis. Mod Rheumatol. 2015;25(1):158–60.
   PubMed Web of Science ®Google Scholar
• Asashima H, Tsuboi H, Takahashi H, Hirota T, Iizuka M, Kondo Y, et al. The anergy induction of M3 muscarinic acetylcholine receptor–reactive CD4+ T cells suppresses experimental sialadenitis-like Sjögren’s syndrome. Arthritis Rheumatol. 2015;67(8):2213–25.
   PubMed Web of Science ®Google Scholar
• Tiwari S, Verma PC, Singh PK, Tuli R. Plants as bioreactors for the production of vaccine antigens. Biotechnol Adv. 2009;27(4):449–67.
   PubMed Web of Science ®Google Scholar
• Yusibov V, Rabindran S. Recent progress in the development of plant-derived vaccines. Expert Rev. Vaccines. 2008;7(8):1173–83.
   PubMed Web of Science ®Google Scholar
• Stoger E, Sack M, Perrin Y, Vaquero C, Torres E, Twyman RM, et al. Practical considerations for pharmaceutical antibody production in different crop systems. Mol Breed. 2002;9(3):149–58.
   Web of Science ®Google Scholar
• Wakasa Y, Takaiwa F. The use of rice seeds to produce human pharmaceuticals for oral therapy. Biotechnol J. 2013;8(10):1133–43.
   PubMed Web of Science ®Google Scholar
• Takagi H, Hiroi T, Hirose S, Yang L, Takaiwa F. Rice seed ER-derived protein body as an efficient delivery vehicle for oral tolerogenic peptides. Peptides 2010;31(8):1421–5.
   PubMed Web of Science ®Google Scholar
• Sloan-Lancaster J, Allen PM. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu Rev Immunol. 1996;14(1):1–27.
   PubMedGoogle Scholar
• Iizuka M, Wakasa Y, Tsuboi H, Asashima H, Hirota T, Kondo Y, et al. Suppression of collagen-induced arthritis by oral administration of transgenic rice seeds expressing altered peptide ligands of type II collagen. Plant Biotechnol J. 2014;12(8):1143–52.
   PubMed Web of Science ®Google Scholar
• Iizuka M, Wakasa Y, Tsuboi H, Asashima H, Hirota T, Kondo Y, et al. Prophylactic effect of the oral administration of transgenic rice seeds containing altered peptide ligands of type II collagen on rheumatoid arthritis. Biosci Biotechnol Biochem. 2014;78(10):1662–8.
   PubMed Web of Science ®Google Scholar
• Hirota T, Tsuboi H, Iizuka-Koga M, Takahashi H, Asashima H, Yokosawa M, et al. Suppression of glucose-6-phosphate-isomerase induced arthritis by oral administration of transgenic rice seeds expressing altered peptide ligands of glucose-6-phosphate-isomerase. Mod Rheumatol. 2017;27.(3):457–65.
   PubMed Web of Science ®Google Scholar
• Tada Y, Utsumi S, Takaiwa F. Foreign gene products can be enhanced by introduction into low storage protein mutants. Plant Biotechnol J. 2003;1(6):411–22.
   PubMed Web of Science ®Google Scholar
• Kawakatsu T, Kawahara Y, Itoh T, Takaiwa F. A whole-genome analysis of a transgenic rice seed-based edible vaccine against cedar pollen allergy. DNA Res. 2013;20(6):623–31.
   PubMed Web of Science ®Google Scholar
• Greenspan JS, Daniels TE, Talal N, Sylvester RA. The histopathology of Sjögren’s syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol. 1974;37(2):217–29.
   PubMedGoogle Scholar
• Fukuda K, Ishida W, Harada Y, Wakasa Y, Takagi H, Takaiwa F, et al. Efficacy of oral immunotherapy with a rice-based edible vaccine containing hypoallergenic Japanese cedar pollen allergens for treatment of established allergic conjunctivitis in mice. Allergol Int. 2018;67(1):119–23.
   PubMed Web of Science ®Google Scholar
• Zhang X-X, Yu H, Wang X-H, Li X-Z, Zhu Y-P, Li H-X, et al. Protective efficacy against Chlamydophila psittaci by oral immunization based on transgenic rice expressing MOMP in mice. Vaccine 2013;31(4):698–703.
   PubMed Web of Science ®Google Scholar
• Aruna V, Sela M, Mozes E. Suppression of myasthenogenic responses of a T cell line by a dual altered peptide ligand by induction of CD4 + CD25+ regulatory cells. Proc Natl Acad Sci USA. 2005;102(29):10285–90.
   PubMed Web of Science ®Google Scholar
• Aruna V, Sela M, Mozes E. Down-regulation of T cell responses to AChR and reversal of EAMG manifestations in mice by a dual altered peptide ligand via induction of CD4 + CD25+ regulatory cells. J Neuroimmunol. 2006;177(1–2):63–75.
   PubMed Web of Science ®Google Scholar
• Dominguez Mdel C, Lorenzo N, Barbera A, Darrasse-Jeze G, Hernández MV, Torres A, et al. An altered peptide ligand corresponding to a novel epitope from heat-shock protein 60 induces regulatory T cells and suppresses pathogenic response in an animal model of adjuvant-induced arthritis. Autoimmunity. 2011;44(6):471–82.
   PubMed Web of Science ®Google Scholar
• Barbera A, Lorenzoa Garridob G, Mazolaa Y, Falccna V, et al. APL-1, an altered peptide ligand derived from human heat-shock protein 60, selectively induces apoptosis in activated CD4 + CD25+ T cells from peripheral blood of rheumatoid arthritis patients. Int Immunopharmacol. 2013;17:1075–83.
   PubMed Web of Science ®Google Scholar
• Anderson P O, Manzo B A, Sundstedt A, Minaee S, Symonds A, Khalid S, et al. Persistent antigenic stimulation alters the transcription program in T cells, resulting in antigen-specific tolerance. Eur J Immunol. 2006;36(6):1374–85.
   PubMed Web of Science ®Google Scholar